| Product NDC: | 59011-445 |
| Proprietary Name: | Dilaudid HP |
| Non Proprietary Name: | hydromorphone hydrochloride |
| Active Ingredient(s): | 10 mg/mL & nbsp; hydromorphone hydrochloride |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59011-445 |
| Labeler Name: | Purdue Pharma LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019034 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19840111 |
| Package NDC: | 59011-445-05 |
| Package Description: | 10 AMPULE in 1 CARTON (59011-445-05) > 5 mL in 1 AMPULE |
| NDC Code | 59011-445-05 |
| Proprietary Name | Dilaudid HP |
| Package Description | 10 AMPULE in 1 CARTON (59011-445-05) > 5 mL in 1 AMPULE |
| Product NDC | 59011-445 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | hydromorphone hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 19840111 |
| Marketing Category Name | NDA |
| Labeler Name | Purdue Pharma LP |
| Substance Name | HYDROMORPHONE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |